期刊文献+

人自噬相关蛋白ATG5的原核表达及纯化

Prokaryotic Expression and Purification of Human ATG5 with His-Tag
下载PDF
导出
摘要 目的:原核表达纯化带His标签的自噬相关蛋白ATG5。方法:利用PCR技术从人乳腺文库中扩增出人ATG5基因的编码序列,插入载体p ET-28a(+)中得到重组质粒,经Bam HⅠ和XhoⅠ双酶切鉴定后转化大肠杆菌Ros-sate进行小量诱导,挑选出可以诱导His-ATG5蛋白的菌液进行融合蛋白的纯化,通过Western印迹和SDS-PAGE检测融合蛋白的纯化效果。结果:用PCR技术从人乳腺文库中扩增得到约828 bp的目的片段,插入载体p ET-28a(+)构建出His-ATG5重组质粒并经酶切及测序验证;转化大肠杆菌Rossate后进行小量诱导表达并纯化蛋白,SDS-PAGE检测显示获得相对分子质量约为38×103的融合蛋白。结论:原核表达并纯化获得His-ATG5融合蛋白,为后续研究ATG5在自噬中的作用机制奠定了实验基础。 Objective: To prokaryotic express human autophagy related protein 5(ATG5) with His-tag and puri-fy the fusion protein. Methods: ATG5 coding region was amplified from human mammary gland c DNA library byPCR, and was cloned into the prokaryotic expression vector p ET-28a(+). The correct recombinant plasmid His-ATG5 was introduced into E.coli Rossate. The expressed recombinant protein was purified by Ni-NTA beads andidentified by SDS-PAGE and Western blot analysis. Results: The DNA fragment of about 828 bp was successful-ly amplified from human mammary gland c DNA library by PCR, and inserted into p ET-28a(+) vector correctly.The results of double digestion and sequencing suggested that the His-ATG5 recombinant plasmid was obtained.His-ATG5 fusion protein of about Mr 38×10^3was induced and identified by SDS-PAGE analysis. Conclusion:The prokaryotic expression protein of His-ATG5 is obtained successfully, which lays the foundation for further re-search on the fuction of ATG5 in autophagy.
出处 《生物技术通讯》 CAS 2016年第2期196-199,共4页 Letters in Biotechnology
基金 国家自然科学基金(81573026 81502264 81472589 31100604) 北京市自然科学基金(7132155) 北京市科技新星计划(Z141102001814055) 军事医学科学院创新基金转化医学项目(ZHYX003)
关键词 人自噬相关蛋白ATG5 原核表达 纯化 自噬 human autophagy related protein 5 prokaryotic expression purification autophagy
  • 相关文献

参考文献7

二级参考文献64

  • 1邹向阳,李连宏.细胞周期调控与肿瘤[J].国际遗传学杂志,2006,29(1):70-73. 被引量:74
  • 2Sevim A, Ismet Y, Hakan V, et al. Genetic evaluation of von Hippel-Lindau disease for early diagnosis and improved prog- nosis[J]. Int Urol Nephrol, 2008,40(3):615-620.
  • 3Melanie G H, Rosanne G, Paul K, et al. yon Hippel-Lindau disease in pregnancy: a brief review[J]. J Clin Neurosci, 2009,16(5):6 ! ! -613.
  • 4Latif F, Tory K, Gnarra J, et al. Identification of the yon Hippel-Lindau disease tumor suppressor gene[J]. Science, 1993,260(5112):1317-1320.
  • 5Patard J J, Leray E, Rioux-Leclereq N, et al. Prognostic val- ue of histologic subtypes in renal cell carcinoma: a multi- center experience[J]. Clin Onco, 2005,23(12):63-71.
  • 6Rodriguez-Gonzalez A, Cyrus K, Salcius M, et al. Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer[J]. Oncogene, 2008,27(57):7201- 7211.
  • 7Nyhan M J, O'Sullivan G C, McKenna S L. Role of the VHL (von Hippel-Lindau) gene in renal cancer: a muhifunctional tumor suppressor[J]. Biochem S: Trans,200836(3):472-478.
  • 8Kibel A, lliopoulos O, DeCaprio J A, et al. Binding of the wm Hippel-Lindau tumor suppressor protein to Elongin B and C[J]. Science, 1995,269(5229):1444-1446.
  • 9Heir P, Sufan R I, Greer S N, et al. DCNL1 functions as a substrate sensor and activator of euUin 2-RING ligase[J]. Mol Cell Biol, 2013,33(8):1621-1631.
  • 10Pause A, Lee S, Worrell R A, et al. The yon Hippel-Lindau tumor-suppressor gene product forms a stable complex withhuman CUL-2, a member of the Cde53 family of proteins[J]. Proe Natl Aead Sei USA, 1997,94(6):2156-2161.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部